Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ADP 101

Drug Profile

ADP 101

Alternative Names: ADP-101

Latest Information Update: 03 Apr 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Stanford University
  • Developer Alladapt Immunotherapeutics
  • Class Antiallergics; Food allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Food hypersensitivity

Most Recent Events

  • 23 Feb 2024 Adverse events and efficacy data from a phase-I/II trial in Food hypersensitivity presented at the 2024 Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI-2024)
  • 22 Nov 2023 ADP 101 receives Fast Track designation for Food hypersensitivity [PO,Powder] (In adolescents, In children, In adults) in USA
  • 09 Nov 2023 Updated adverse events and efficacy data from a phase I/II Harmony trial in Food Hypersensitivity presented at the American College of Allergy, Asthma & Immunology (AAAAI-2023)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top